A dossier for the active substance Novaluron was submitted by Makhteshim Agan Ltd, United Kingdom, to the authorities of the United Kingdom on 29 March 2001 with an application to obtain its inclusion in Annex I to Directive 91/414/EEC. For the active substance Laminarin an application was submitted by Laboratories Go?mar SA, France, to the authorities of Belgium on 29 March 2001.
